<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28352665</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2379-3708</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>2</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Mar</Month>
              <Day>23</Day>
            </PubDate>
          </JournalIssue>
          <Title>JCI insight</Title>
          <ISOAbbreviation>JCI Insight</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.</ArticleTitle>
        <Pagination>
          <StartPage>e91863</StartPage>
          <MedlinePgn>e91863</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e91863</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.91863</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">91863</ELocationID>
        <Abstract>
          <AbstractText>Insulin can inhibit hepatic glucose production (HGP) by acting directly on the liver as well as indirectly through effects on adipose tissue, pancreas, and brain. While insulin's indirect effects are indisputable, their physiologic role in the suppression of HGP seen in response to increased insulin secretion is not clear. Likewise, the mechanisms by which insulin suppresses lipolysis and pancreatic α cell secretion under physiologic circumstances are also debated. In this study, insulin was infused into the hepatic portal vein to mimic increased insulin secretion, and insulin's indirect liver effects were blocked either individually or collectively. During physiologic hyperinsulinemia, plasma free fatty acid (FFA) and glucagon levels were clamped at basal values and brain insulin action was blocked, but insulin's direct effects on the liver were left intact. Insulin was equally effective at suppressing HGP when its indirect effects were absent as when they were present. In addition, the inhibition of lipolysis, as well as glucagon and insulin secretion, did not require CNS insulin action or decreased plasma FFA. This indicates that the rapid suppression of HGP is attributable to insulin's direct effect on the liver and that its indirect effects are redundant in the context of a physiologic increase in insulin secretion.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Edgerton</LastName>
            <ForeName>Dale S</ForeName>
            <Initials>DS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kraft</LastName>
            <ForeName>Guillaume</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Marta</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farmer</LastName>
            <ForeName>Ben</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Williams</LastName>
            <ForeName>Phillip E</ForeName>
            <Initials>PE</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Surgical Research, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Coate</LastName>
            <ForeName>Katie C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Samford University, Department of Nutrition and Dietetics, Birmingham, Alabama, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Printz</LastName>
            <ForeName>Richard L</ForeName>
            <Initials>RL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Brien</LastName>
            <ForeName>Richard M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cherrington</LastName>
            <ForeName>Alan D</ForeName>
            <Initials>AD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DK018243</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JCI Insight</MedlineTA>
        <NlmUniqueID>101676073</NlmUniqueID>
        <ISSNLinking>2379-3708</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005230">Fatty Acids, Nonesterified</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9007-92-5</RegistryNumber>
          <NameOfSubstance UI="D005934">Glucagon</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005230" MajorTopicYN="N">Fatty Acids, Nonesterified</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005934" MajorTopicYN="N">Glucagon</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008066" MajorTopicYN="N">Lipolysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Conflict of interest: The authors have declared that no conflict of interest exists.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28352665</ArticleId>
        <ArticleId IdType="pmc">PMC5358484</ArticleId>
        <ArticleId IdType="doi">10.1172/jci.insight.91863</ArticleId>
        <ArticleId IdType="pii">91863</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Edgerton DS, et al.  Insulin’s direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest. 2006;116(2):521–527. doi: 10.1172/JCI27073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI27073</ArticleId>
            <ArticleId IdType="pmc">PMC1359060</ArticleId>
            <ArticleId IdType="pubmed">16453026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hausler N, et al.  Effects of insulin and cytosolic redox state on glucose production pathways in the isolated perfused mouse liver measured by integrated 2H and 13C NMR. Biochem J. 2006;394(Pt 2):465–473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1408677</ArticleId>
            <ArticleId IdType="pubmed">16288601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maheux P, Chen YD, Polonsky KS, Reaven GM. Evidence that insulin can directly inhibit hepatic glucose production. Diabetologia. 1997;40(11):1300–1306. doi: 10.1007/s001250050824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s001250050824</ArticleId>
            <ArticleId IdType="pubmed">9389422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pilkis SJ, el-Maghrabi MR, Claus TH. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem. 1988;57:755–783.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3052289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes. 1996;45(11):1594–1604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8866566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes. 1998;47(4):523–529. doi: 10.2337/diabetes.47.4.523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.47.4.523</ArticleId>
            <ArticleId IdType="pubmed">9568682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boden G, Cheung P, Homko C. Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes. Diabetes. 2003;52(1):133–137. doi: 10.2337/diabetes.52.1.133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.52.1.133</ArticleId>
            <ArticleId IdType="pubmed">12502503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edgerton DS, et al.  Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes. 2001;50(8):1872–1882. doi: 10.2337/diabetes.50.8.1872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.50.8.1872</ArticleId>
            <ArticleId IdType="pubmed">11473051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramnanan CJ, et al.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes. 2010;59(6):1302–1311. doi: 10.2337/db09-1625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-1625</ArticleId>
            <ArticleId IdType="pmc">PMC2874690</ArticleId>
            <ArticleId IdType="pubmed">20185816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis GF, Vranic M, Harley P, Giacca A. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes. 1997;46(7):1111–1119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9200644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry RJ, et al.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745–758. doi: 10.1016/j.cell.2015.01.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.01.012</ArticleId>
            <ArticleId IdType="pmc">PMC4498261</ArticleId>
            <ArticleId IdType="pubmed">25662011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996;98(3):741–749. doi: 10.1172/JCI118846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI118846</ArticleId>
            <ArticleId IdType="pmc">PMC507484</ArticleId>
            <ArticleId IdType="pubmed">8698866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 1997;46(2):187–196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9000693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Titchenell PM, et al.  Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production. Cell Metab. 2016;23(6):1154–1166. doi: 10.1016/j.cmet.2016.04.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2016.04.022</ArticleId>
            <ArticleId IdType="pmc">PMC4909537</ArticleId>
            <ArticleId IdType="pubmed">27238637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherrington AD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes. 1999;48(5):1198–1214. doi: 10.2337/diabetes.48.5.1198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.48.5.1198</ArticleId>
            <ArticleId IdType="pubmed">10331429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis GF, Vranic M, Giacca A. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol. 1997;272(3 Pt 1):E371–E378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9124541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002;8(12):1376–1382. doi: 10.1038/nm1202-798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1202-798</ArticleId>
            <ArticleId IdType="pubmed">12426561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pocai A, et al.  Hypothalamic K(ATP) channels control hepatic glucose production. Nature. 2005;434(7036):1026–1031. doi: 10.1038/nature03439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03439</ArticleId>
            <ArticleId IdType="pubmed">15846348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes. 1996;45(4):454–462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8603767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fisher SJ, Kahn CR. Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production. J Clin Invest. 2003;111(4):463–468. doi: 10.1172/JCI16426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI16426</ArticleId>
            <ArticleId IdType="pmc">PMC151923</ArticleId>
            <ArticleId IdType="pubmed">12588884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherrington AD, Liljenquist JE, Shulman GI, Williams PE, Lacy WW. Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. Am J Physiol. 1979;236(3):E263–E271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">426057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramnanan CJ, et al.  Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J Clin Invest. 2011;121(9):3713–3723. doi: 10.1172/JCI45472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI45472</ArticleId>
            <ArticleId IdType="pmc">PMC3163950</ArticleId>
            <ArticleId IdType="pubmed">21865644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greco AV, et al.  Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis. Diabetologia. 1979;17(1):23–28. doi: 10.1007/BF01222973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01222973</ArticleId>
            <ArticleId IdType="pubmed">467851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 1975;55(6):1278–1283. doi: 10.1172/JCI108047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI108047</ArticleId>
            <ArticleId IdType="pmc">PMC301883</ArticleId>
            <ArticleId IdType="pubmed">1133173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edgerton DS, et al.  Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog. Diabetes. 2014;63(11):3946–3954. doi: 10.2337/db14-0266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-0266</ArticleId>
            <ArticleId IdType="pmc">PMC4392933</ArticleId>
            <ArticleId IdType="pubmed">24947349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farmer TD, et al.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp. Am J Physiol Endocrinol Metab. 2015;308(3):E206–E222. doi: 10.1152/ajpendo.00406.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00406.2014</ArticleId>
            <ArticleId IdType="pmc">PMC4312835</ArticleId>
            <ArticleId IdType="pubmed">25516552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prager R, Wallace P, Olefsky JM. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes. 1987;36(5):607–611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3552793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buettner C, et al.  Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. J Clin Invest. 2005;115(5):1306–1313. doi: 10.1172/JCI23109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI23109</ArticleId>
            <ArticleId IdType="pmc">PMC1087163</ArticleId>
            <ArticleId IdType="pubmed">15864350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okamoto H, Obici S, Accili D, Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest. 2005;115(5):1314–1322. doi: 10.1172/JCI23096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI23096</ArticleId>
            <ArticleId IdType="pmc">PMC1087162</ArticleId>
            <ArticleId IdType="pubmed">15864351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR. Quantifying gluconeogenesis during fasting. Am J Physiol. 1997;273(6 Pt 1):E1209–E1215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9435538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edgerton DS, et al.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo. Diabetes. 2009;58(12):2766–2775. doi: 10.2337/db09-0328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-0328</ArticleId>
            <ArticleId IdType="pmc">PMC2780867</ArticleId>
            <ArticleId IdType="pubmed">19755527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science. 1991;254(5031):573–576. doi: 10.1126/science.1948033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1948033</ArticleId>
            <ArticleId IdType="pubmed">1948033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C, Williams PF, Cooney GJ, Caterson ID, Turtle JR. The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice. Horm Metab Res. 1992;24(4):161–166. doi: 10.1055/s-2007-1003285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-1003285</ArticleId>
            <ArticleId IdType="pubmed">1601390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braun M, Ramracheya R, Rorsman P. Autocrine regulation of insulin secretion. Diabetes Obes Metab. 2012;14 Suppl 3:143–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22928575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr. 2008;28:233–251. doi: 10.1146/annurev.nutr.28.061807.155530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.nutr.28.061807.155530</ArticleId>
            <ArticleId IdType="pubmed">18481923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhodes CJ, White MF, Leahy JL, Kahn SE. Direct autocrine action of insulin on β-cells: does it make physiological sense? Diabetes. 2013;62(7):2157–2163. doi: 10.2337/db13-0246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db13-0246</ArticleId>
            <ArticleId IdType="pmc">PMC3712043</ArticleId>
            <ArticleId IdType="pubmed">23801714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007;27:79–101. doi: 10.1146/annurev.nutr.27.061406.093734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.nutr.27.061406.093734</ArticleId>
            <ArticleId IdType="pmc">PMC2885771</ArticleId>
            <ArticleId IdType="pubmed">17313320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007;28(1):84–116. doi: 10.1210/er.2006-0007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2006-0007</ArticleId>
            <ArticleId IdType="pubmed">17261637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quesada I, Tudurí E, Ripoll C, Nadal A. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199(1):5–19. doi: 10.1677/JOE-08-0290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1677/JOE-08-0290</ArticleId>
            <ArticleId IdType="pubmed">18669612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue H, et al.  Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 2006;3(4):267–275. doi: 10.1016/j.cmet.2006.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2006.02.009</ArticleId>
            <ArticleId IdType="pubmed">16581004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koch L, et al.  Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118(6):2132–2147. doi: 10.1172/JCI31073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI31073</ArticleId>
            <ArticleId IdType="pmc">PMC2350427</ArticleId>
            <ArticleId IdType="pubmed">18451994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramnanan CJ, et al.  Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog. Diabetes. 2013;62(1):74–84. doi: 10.2337/db12-0148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db12-0148</ArticleId>
            <ArticleId IdType="pmc">PMC3526039</ArticleId>
            <ArticleId IdType="pubmed">23011594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girard J. The inhibitory effects of insulin on hepatic glucose production are both direct and indirect. Diabetes. 2006;55:S65–SS9. doi: 10.2337/db06-S009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db06-S009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grayson BE, Seeley RJ, Sandoval DA. Wired on sugar: the role of the CNS in the regulation of glucose homeostasis. Nat Rev Neurosci. 2013;14(1):24–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4231433</ArticleId>
            <ArticleId IdType="pubmed">23232606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Könner AC, et al.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 2007;5(6):438–449. doi: 10.1016/j.cmet.2007.05.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2007.05.004</ArticleId>
            <ArticleId IdType="pubmed">17550779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin HV, et al.  Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes. 2010;59(2):337–346. doi: 10.2337/db09-1303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-1303</ArticleId>
            <ArticleId IdType="pmc">PMC2809966</ArticleId>
            <ArticleId IdType="pubmed">19933998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogt MC, Brüning JC. CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age. Trends Endocrinol Metab. 2013;24(2):76–84. doi: 10.1016/j.tem.2012.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tem.2012.11.004</ArticleId>
            <ArticleId IdType="pubmed">23265947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coomans CP, et al.  Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice. Diabetes. 2011;60(12):3132–3140. doi: 10.2337/db10-1100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db10-1100</ArticleId>
            <ArticleId IdType="pmc">PMC3219951</ArticleId>
            <ArticleId IdType="pubmed">22028182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coomans CP, et al.  Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulin-sensitive mice. J Lipid Res. 2011;52(9):1712–1722. doi: 10.1194/jlr.M015396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1194/jlr.M015396</ArticleId>
            <ArticleId IdType="pmc">PMC3151691</ArticleId>
            <ArticleId IdType="pubmed">21700834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest. 1997;100(12):3121–3130. doi: 10.1172/JCI119867.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI119867</ArticleId>
            <ArticleId IdType="pmc">PMC508525</ArticleId>
            <ArticleId IdType="pubmed">9399959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jurczak MJ, et al.  Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice. J Biol Chem. 2012;287(4):2558–2567. doi: 10.1074/jbc.M111.316760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.316760</ArticleId>
            <ArticleId IdType="pmc">PMC3268415</ArticleId>
            <ArticleId IdType="pubmed">22128176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 2012;16(4):500–510. doi: 10.1016/j.cmet.2012.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.09.005</ArticleId>
            <ArticleId IdType="pubmed">23040071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Persaud SJ, Asare-Anane H, Jones PM. Insulin receptor activation inhibits insulin secretion from human islets of Langerhans. FEBS Lett. 2002;510(3):225–228. doi: 10.1016/S0014-5793(01)03268-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0014-5793(01)03268-9</ArticleId>
            <ArticleId IdType="pubmed">11801259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawamori D, et al.  Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 2009;9(4):350–361. doi: 10.1016/j.cmet.2009.02.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2009.02.007</ArticleId>
            <ArticleId IdType="pmc">PMC2694613</ArticleId>
            <ArticleId IdType="pubmed">19356716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paranjape SA, et al.  Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes. 2010;59(6):1521–1527. doi: 10.2337/db10-0014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db10-0014</ArticleId>
            <ArticleId IdType="pmc">PMC2874714</ArticleId>
            <ArticleId IdType="pubmed">20299468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scherer T, et al.  Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 2011;13(2):183–194. doi: 10.1016/j.cmet.2011.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2011.01.008</ArticleId>
            <ArticleId IdType="pmc">PMC3061443</ArticleId>
            <ArticleId IdType="pubmed">21284985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen M, Woods SC, Porte D. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog. Diabetes. 1975;24(10):910–914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1100460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang TT, Ling SM, Tsao CW, Cheng JT. Opening of ATP-sensitive potassium channel by insulin in the brain-induced insulin secretion in Wistar rats. Horm Metab Res. 2010;42(2):110–114. doi: 10.1055/s-0029-1241822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0029-1241822</ArticleId>
            <ArticleId IdType="pubmed">19890806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dash S, Xiao C, Morgantini C, Koulajian K, Lewis GF. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations. Diabetes. 2015;64(3):766–774. doi: 10.2337/db14-0685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-0685</ArticleId>
            <ArticleId IdType="pubmed">25288674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bollheimer LC, et al.  Stimulatory short-term effects of free fatty acids on glucagon secretion at low to normal glucose concentrations. Metab Clin Exp. 2004;53(11):1443–1448. doi: 10.1016/j.metabol.2004.06.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.metabol.2004.06.011</ArticleId>
            <ArticleId IdType="pubmed">15536599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stagner J, Samols E, Polonsky K, Pugh W. Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas. J Clin Invest. 1986;78(5):1193–1198. doi: 10.1172/JCI112702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI112702</ArticleId>
            <ArticleId IdType="pmc">PMC423804</ArticleId>
            <ArticleId IdType="pubmed">2877010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boden G. Free fatty acids and insulin secretion in humans. Curr Diab Rep. 2005;5(3):167–170. doi: 10.1007/s11892-005-0004-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11892-005-0004-5</ArticleId>
            <ArticleId IdType="pubmed">15929861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore MC, Coate KC, Winnick JJ, An Z, Cherrington AD. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr. 2012;3(3):286–294. doi: 10.3945/an.112.002089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3945/an.112.002089</ArticleId>
            <ArticleId IdType="pmc">PMC3649460</ArticleId>
            <ArticleId IdType="pubmed">22585902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore MC, Connolly CC, Cherrington AD. Autoregulation of hepatic glucose production. Eur J Endocrinol. 1998;138(3):240–248. doi: 10.1530/eje.0.1380240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/eje.0.1380240</ArticleId>
            <ArticleId IdType="pubmed">9539293</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
